ClearPoint Neuro(us:CLPT)

    14.57

    -6.30%

    Updated on 2024-12-23

    Open:15.57
    Close:14.57
    High:15.60
    Low:14.40
    Pre Close:15.55
    Volume:132203.00
    Amount:1.95M
    Turnover:0.48%
    Shares:27.58M
    MarketCap:402.05M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-3099705083525.56%211935
    2024-03-3184751603027.41%152229
    2023-12-3174629317925.53%131824
    2023-09-3068593201024.09%121620
    2023-06-3076579436623.53%172031
    2023-03-3168454411018.49%102421
    2022-12-3170416894616.96%142023
    2022-09-3065371071315.15%151721
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Blackrock Inc.14739735.38%39170.27%
    2024-03-31Vanguard Group Inc13076994.77%-995-0.08%
    2024-03-31Geode Capital Management, Llc5130331.87%238784.88%
    2024-03-31Taylor Frigon Capital Management Llc4240971.55%7149120.27%
    2024-03-31State Street Corp4162761.52%6737819.31%
    2024-03-31Cm Management, Llc3750001.37%17500087.50%
    2024-03-31Brown Advisory Inc3333951.22%0
    2024-03-31Essex Investment Management Co Llc3298791.20%329879
    2024-03-31Cahill Wealth Management, Llc2443870.89%121245.22%
    2024-03-31Northern Trust Corp1978190.72%-66-0.03%

    About

    Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.
    Address:120 South Sierra Avenue,Suite 100

    Market Movers